A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/17363544

Clin. Cancer Res. 2007 Mar 15 13 6 1875-82

Download in:

View as

General Info

PMID
17363544